Clinical Genetics · Los Angeles, CA
NPI
1275612749
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Medical Plaza Suite 3100
Los Angeles, CA, 90095
Phone (310) 301-8732
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,118
24 services
Medicare patients, 2024
11
Average age 63
Drug cost, 2024
$940K
45 prescriptions
Company payments, 2025
$49K
From 8 companies
Medicare prescription drug claims, 2024
In 2024, the drug Nicola Longo prescribed most often to Medicare patients was Carbamazepine, with 14 prescriptions and refills. In total Nicola Longo wrote 45 Medicare prescriptions that cost $940K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Carbamazepine Generic | 14 | 14 | Under 11 | $1,135 |
| Nexviazyme Avalglucosidase Alfa-Ngpt | 13 | 13 | Under 11 | $835K |
| Miglustat Generic | 11 | 11 | Under 11 | $21K |
Brand drugs: 18 claims; generic drugs: 27 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicola Longo $49K ($49K in general payments such as food, travel and fees) from 8 companies. The largest payer was PTC Therapeutics, Inc. with $24K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.